Notably, Egr1 has been reported to be a transcriptional target of SRC-211, 33 and is implicated in promotion of obesity and insulin resistance34, progression of prostate cancer35 and transcriptional regulation of lipid and cholesterol biosynthetic genes36. Here, EGR1 is linked to obesity disorder.